80 related articles for article (PubMed ID: 25275165)
1. Investigation of the influence of vanadium compounds treatment in NZO mice model--preliminary study.
Krośniak M; Francik R; Kołodziejczyk K; Wojtanowska-Krośniak A; Tedeschi C; Petrone V; Gryboś R
Acta Pol Pharm; 2014; 71(2):271-8. PubMed ID: 25275165
[TBL] [Abstract][Full Text] [Related]
2. Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?
Huang M; Wu Y; Wang N; Wang Z; Zhao P; Yang X
Biol Trace Elem Res; 2014 Mar; 157(3):242-8. PubMed ID: 24446192
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antidiabetic potential of oyster mushroom (Pleurotus ostreatus) in alloxan-induced diabetic mice.
Ravi B; Renitta RE; Prabha ML; Issac R; Naidu S
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):101-9. PubMed ID: 22867521
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
6. Rhodiola crenulata root ameliorates derangements of glucose and lipid metabolism in a rat model of the metabolic syndrome and type 2 diabetes.
Wang J; Rong X; Li W; Yang Y; Yamahara J; Li Y
J Ethnopharmacol; 2012 Aug; 142(3):782-8. PubMed ID: 22683493
[TBL] [Abstract][Full Text] [Related]
7. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
8. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
[TBL] [Abstract][Full Text] [Related]
9. Preventive and curative effect of Trigonella foenum-graecum L. seeds in C57BL/6J models of type 2 diabetes induced by high-fat diet.
Hamza N; Berke B; Cheze C; Le Garrec R; Umar A; Agli AN; Lassalle R; Jové J; Gin H; Moore N
J Ethnopharmacol; 2012 Jul; 142(2):516-22. PubMed ID: 22633967
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats.
Dyrskog SE; Jeppesen PB; Colombo M; Abudula R; Hermansen K
Metabolism; 2005 Sep; 54(9):1181-8. PubMed ID: 16125530
[TBL] [Abstract][Full Text] [Related]
11. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
Lloyd DJ; Helmering J; Cordover D; Bowsman M; Chen M; Hale C; Fordstrom P; Zhou M; Wang M; Kaufman SA; Véniant MM
Diabetes Obes Metab; 2009 Jul; 11(7):688-99. PubMed ID: 19527482
[TBL] [Abstract][Full Text] [Related]
13. The potentiality of vanadium in medicinal applications.
Rehder D
Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
[TBL] [Abstract][Full Text] [Related]
14. Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats.
Koyuturk M; Tunali S; Bolkent S; Yanardag R
Biol Trace Elem Res; 2005 Jun; 104(3):233-47. PubMed ID: 15930593
[TBL] [Abstract][Full Text] [Related]
15. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
Xie M; Gao L; Li L; Liu W; Yan S
J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
[TBL] [Abstract][Full Text] [Related]
16. [The vanadium compounds: chemistry, synthesis, insulinomimetic properties].
Fedorova EV; Buriakina AV; Vorob'eva NM; Baranova NI
Biomed Khim; 2014; 60(4):416-29. PubMed ID: 25249525
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
18. [Hypoglyceminc effect of flavonoids from Prinsepia utilis on alloxan-induced diabetic mice].
Jia RY; Yin ZQ; Wu XL; Liu DB; Du YH; Luo LY; Li C; Xiong Y
Zhong Yao Cai; 2008 Mar; 31(3):399-403. PubMed ID: 18619247
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a new insulin-mimetic anti-diabetic drug containing vitamin A and vanadium(IV) salt: Chemico-biological characterizations.
Adam AMA; Naglah AM; Al-Omar MA; Refat MS
Int J Immunopathol Pharmacol; 2017 Sep; 30(3):272-281. PubMed ID: 28731364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
